1-18 of 18
Gilles Salles
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma

Open Access
Xavier Deschênes-Simard, Maria Bromberg, Sean M. Devlin, Mithat Gonen, Ofrat Beyar-Katz, Andrew Ip, Ronit Marcus, Abraham Avigdor, Annamaria Ballweg, Emma Rabinovich, Mohammad Alhomoud, Alfredo Rivas Delgado, Magdalena Corona De Lapuerta, Alejandro Luna De Abia, Maria Lia Palomba, Gunjan L. Shah, Richard Lin, Alexander P. Boardman, Lorenzo Falchi, Jennifer Lue, Gilles Salles, Miguel-Angel Perales, Roni Shouval, Parastoo B. Dahi, Michael Scordo
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5571–5584.
https://doi.org/10.1182/bloodadvances.2025016778
Published: 2025
Includes: Supplemental data
Journal Articles

BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants

Open Access
Paola Ghione, Diana Mandelker, Maria Arcila, Venkatraman Seshan, Mary Beth Terry, Joseph Vijai, Peter Cordeiro, Chad Vanderbilt, Joyce Pressley, Alexander Chan, Natasha Galasso, Ahmet Dogan, Gilles Salles, Daphne de Jong, Flora van Leeuwen, Steven Horwitz
Journal: Blood Advances
Blood Adv (2025) 9 (17): 4436–4443.
https://doi.org/10.1182/bloodadvances.2025016810
Published: 2025
Journal Articles

Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes

Open Access
Clinical Trials & Observations
Marek Trněný, Laura Fogliatto, Faithlore Gardner, Ian Flinn, Jean-François Larouche, Corinne Haioun, Miguel Canales, Hideki Goto, Roman Hajek, Gilles Salles, Avrita Singh, Mark Yan, Rucha Kothari, Gabriel Man, Deniz Sahin, Jamie Hirata, Calvin Lee, Hervé Tilly, Christopher R. Flowers
Journal: Blood Advances
Blood Adv (2025) 9 (13): 3263–3267.
https://doi.org/10.1182/bloodadvances.2024014695
Published: 2025
Journal Articles

Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes

Free
Yannis K. Valtis, Sean Devlin, Roni Shouval, Kai Rejeski, Magdalena Corona, Alejandro Luna De Abia, Alfredo Rivas-Delgado, Efrat Luttwak, Giulio Cassanello, Ivan Landego, Heiko Schöder, Akshay Bedmutha, Alexander Boardman, Gunjan L. Shah, Michael Scordo, Miguel-Angel Perales, Gilles Salles, M. Lia Palomba, Urvi A. Shah, Jae H. Park
Journal: Blood Advances
Blood Adv (2024) 9 (1): 151–161.
https://doi.org/10.1182/bloodadvances.2024014555
Published: 2024
Includes: Supplemental data
Journal Articles

CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas

Free
Clinical Trials & Observations
Gustav Y. Cederquist, Javin Schefflein, Sean M. Devlin, Gunjan L. Shah, Roni Shouval, Harper Hubbeling, Kathryn Tringale, Ana Alarcon Tomas, Beatrice Fregonese, Carla Hajj, Alexander Boardman, Alejandro Luna De Abia, Magdalena Corona, Giulio Cassanello, Parastoo B. Dahi, Richard J. Lin, Paola Ghione, Gilles Salles, Miguel-Angel Perales, M. Lia Palomba, Lorenzo Falchi, Michael Scordo, Christian Grommes, Joachim Yahalom, Brandon S. Imber
Journal: Blood Advances
Blood Adv (2024) 8 (19): 5192–5199.
https://doi.org/10.1182/bloodadvances.2024013393
Published: 2024
Includes: Supplemental data
Journal Articles

Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma

Free
Clinical Trials & Observations
Pier Luigi Zinzani, Gilles Salles, Alison J. Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M. Barr, Neha Mehta-Shah, Graham P. Collins, Stephen M. Ansell, Joshua D. Brody, Eva Domingo-Domenech, Nathalie A. Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry J. Savage
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2400–2404.
https://doi.org/10.1182/bloodadvances.2023011030
Published: 2024
Includes: Supplemental data
Journal Articles

Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma

Free
Clinical Trials & Observations
Loretta J. Nastoupil, Georg Hess, Miguel A. Pavlovsky, Iwona Danielewicz, Jane Freeman, Alejandro Martin García-Sancho, Valeria Glazunova, Andrew Grigg, Jing-Zhou Hou, Ann Janssens, Seok Jin Kim, Zvenyslava Masliak, Pam McKay, Francesco Merli, Wataru Munakata, Hirokazu Nagai, Muhit Özcan, Meir Preis, Tingyu Wang, Melissa Rowe, Monelle Tamegnon, Rui Qin, Todd Henninger, Madeliene Curtis, Donne Bennett Caces, Catherine Thieblemont, Gilles Salles
Journal: Blood Advances
Blood Adv (2023) 7 (22): 7141–7150.
https://doi.org/10.1182/bloodadvances.2023010298
Published: 2023
Includes: Supplemental data
Journal Articles

TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

Free
William T. Johnson, Nivetha Ganesan, Zachary D. Epstein-Peterson, Alison J. Moskowitz, Robert N. Stuver, Catherine R. Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan, Umut Aypar, Natasha E. Lewis, Andrew D. Zelenetz, M. Lia Palomba, Matthew J. Matasar, Ariela Noy, Audrey M. Hamilton, Paul Hamlin, Philip C. Caron, David J. Straus, Andrew M. Intlekofer, Connie Lee Batlevi, Anita Kumar, Colette N. Owens, Craig S. Sauter, Lorenzo Falchi, Jennifer K. Lue, Santosha A. Vardhana, Gilles Salles, Ahmet Dogan, Nikolaus D. Schultz, Maria E. Arcila, Steven M. Horwitz
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5172–5186.
https://doi.org/10.1182/bloodadvances.2023009953
Published: 2023
Includes: Supplemental data
Journal Articles

Retrospective characterization of nodal marginal zone lymphoma

Free
Robert Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C. Caron, Ahmet Dogan, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paul A. Hamlin, Steven M. Horwitz, Brandon S. Imber, Andrew M. Intlekofer, William T. Johnson, Niloufer Khan, Anita Kumar, Oscar B. Lahoud, Jennifer Kimberly Lue, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette N. Owens, M. Lia Palomba, Heiko Schöder, Santosha A. Vardhana, Joachim Yahalom, Andrew D. Zelenetz, Gilles Salles, David J. Straus
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4838–4847.
https://doi.org/10.1182/bloodadvances.2022009587
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma

Free
Gilles Salles, Stephen J. Schuster, Martin Dreyling, Luca Fischer, John Kuruvilla, Piers E. M. Patten, Bastian von Tresckow, Sonali M. Smith, Ana Jiménez-Ubieto, Keith L. Davis, Carla Anjos, Jufen Chu, Jie Zhang, Chiara Lobetti Bodoni, Catherine Thieblemont, Nathan H. Fowler, Michael Dickinson, Joaquin Martínez-López, Yucai Wang, Brian K. Link
Journal: Blood Advances
Blood Adv (2022) 6 (22): 5835–5843.
https://doi.org/10.1182/bloodadvances.2022008150
Published: 2022
Journal Articles

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

Free
G. Tjitske Los-de Vries, Wendy B. C. Stevens, Erik van Dijk, Carole Langois-Jacques, Andrew J. Clear, Phylicia Stathi, Margaretha G. M. Roemer, Matias Mendeville, Nathalie J. Hijmering, Birgitta Sander, Andreas Rosenwald, Maria Calaminici, Eva Hoster, Wolfgang Hiddemann, Philippe Gaulard, Gilles Salles, Heike Horn, Wolfram Klapper, Luc Xerri, Catherine Burton, Reuben M. Tooze, Alexandra G. Smith, Christian Buske, David W. Scott, Yasodha Natkunam, Ranjana Advani, Laurie H. Sehn, John Raemaekers, John Gribben, Eva Kimby, Marie José Kersten, Delphine Maucort-Boulch, Bauke Ylstra, Daphne de Jong
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5482–5493.
https://doi.org/10.1182/bloodadvances.2022008355
Published: 2022
Includes: Supplemental data
Journal Articles

A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma

Free
Clinical Trials & Observations
David Qualls, Hiu Ying Lam, Karissa Whiting, Anita Kumar, Matthew Matasar, Colette Owens, Chelsea Nichols, James A Espeleta, Annie Qiu, Sarima Subzwari, Erin Biggar, Venkatraman Seshan, Gilles Salles, Anas Younes, Connie Batlevi
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5262–5266.
https://doi.org/10.1182/bloodadvances.2021006555
Published: 2022
Includes: Supplemental data
Journal Articles

Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma

Free
Clinical Trials & Observations
Ulrich Jaeger, Constantine S. Tam, Peter Borchmann, Joseph P. McGuirk, Marianne Johansen, Edmund K. Waller, Samantha Jaglowski, Charalambos Andreadis, Stephen R. Foley, Jason R. Westin, Isabelle Fleury, P. Joy Ho, Stephan Mielke, Takanori Teshima, Gilles Salles, Stephen J. Schuster, Fiona He, Richard T. Maziarz, Sebastian Mayer, Shinichi Makita, Marie J. Kersten, Monalisa Ghosh, Nina Wagner-Johnston, Koji Kato, Paolo Corradini, Hideki Goto, Silvia Colicino, Abhijit Agarwal, Chiara Lobetti-Bodoni, Michael R. Bishop
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4816–4820.
https://doi.org/10.1182/bloodadvances.2021006193
Published: 2022
Includes: Supplemental data
Journal Articles

Indirect comparison of tisagenlecleucel and historical treatments for relapsed/refractory diffuse large B-cell lymphoma

Free
Clinical Trials & Observations
Richard T. Maziarz, Jie Zhang, Hongbo Yang, Xinglei Chai, Chengbo Yuan, Elisabeth Schwarz, Mihael Jakovac, Marcela Martinez-Prieto, Abhijit Agarwal, Evgeny Degtyarev, Constantine Tam, Gilles Salles
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2536–2547.
https://doi.org/10.1182/bloodadvances.2021006280
Published: 2022
Includes: Supplemental data
Journal Articles

Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data

Free
Clinical Trials & Observations
Laurie H. Sehn, Mark Hertzberg, Stephen Opat, Alex F. Herrera, Sarit Assouline, Christopher R. Flowers, Tae Min Kim, Andrew McMillan, Muhit Ozcan, Violaine Safar, Gilles Salles, Grace Ku, Jamie Hirata, Yi Meng Chang, Lisa Musick, Matthew J. Matasar
Journal: Blood Advances
Blood Adv (2022) 6 (2): 533–543.
https://doi.org/10.1182/bloodadvances.2021005794
Published: 2022
Includes: Supplemental data
Journal Articles

Early progression of disease in follicular lymphoma is a robust correlate but not a surrogate for overall survival

Free
Clinical Trials & Observations
Emmanuel Bachy, James R. Cerhan, Gilles Salles
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1729–1732.
https://doi.org/10.1182/bloodadvances.2020003797
Published: 2021
Includes: Supplemental data
Journal Articles

Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL

Free
Clinical Trials & Observations
Rakesh Awasthi, Lida Pacaud, Edward Waldron, Constantine S. Tam, Ulrich Jäger, Peter Borchmann, Samantha Jaglowski, Stephen Ronan Foley, Koen van Besien, Nina D. Wagner-Johnston, Marie José Kersten, Stephen J. Schuster, Gilles Salles, Richard T. Maziarz, Özlem Anak, Christopher del Corral, Jufen Chu, Irina Gershgorin, Iulian Pruteanu-Malinici, Abhijit Chakraborty, Karen Thudium Mueller, Edmund K. Waller
Journal: Blood Advances
Blood Adv (2020) 4 (3): 560–572.
https://doi.org/10.1182/bloodadvances.2019000525
Published: 2020
Includes: Supplemental data
Journal Articles

Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets

Free
Christopher R. Bolen, Ronald McCord, Sarah Huet, Garrett M. Frampton, Richard Bourgon, Fabrice Jardin, Peggy Dartigues, Elizabeth A. Punnoose, Edith Szafer-Glusman, Luc Xerri, Pierre Sujobert, Gilles Salles, Jeffrey M. Venstrom
Journal: Blood Advances
Blood Adv (2017) 1 (22): 1884–1890.
https://doi.org/10.1182/bloodadvances.2016000786
Published: 2017
Includes: Supplemental data